- In July 2023, Carer, an oncology-focused organization in India, announced a partnership with Wholeleaf, a certified medicinal cannabis and cannabidiol producer. The collaboration is designed to enhance cancer patient care by providing nutrition support for caregivers, along with physical therapy and mental health services. With approval from the Ayush Ministry, both companies plan to manufacture and distribute their products nationwide, offering a holistic approach to cancer treatment
- In February 2023, Aurora Cannabis Inc., a Canadian global cannabis distributor, partnered with MedReleaf Australia to introduce CraftPlant, a new medical cannabis brand tailored for the Australian market. The brand's first three strains—Greendae, Navana, and HiVolt—feature high THC concentrations, are developed by Aurora’s genetics division Occo, and are packaged in 10g canisters produced under strict EU-GMP-certified standards
- In September 2022, Alternaleaf, a renowned clinic assisting Australians in accessing medicinal cannabis, announced its expansion into the United Kingdom. Research forecasts that England is set to become Europe's second-largest market for medicinal cannabis, largely driven by rising demand and a growing opioid addiction crisis, which medicinal cannabis could help alleviate
- In April 2022, MediCane Health Inc. and Dr. Reddy’s Laboratories Ltd. launched a medical cannabis product in Germany to address the rising demand for therapeutic cannabis treatments. This partnership marks an important step in expanding patient access to medical cannabis solutions across the German healthcare market
- In April 2022, New York City celebrated its first legal sales of recreational marijuana, just one month after seven licensed medical marijuana companies were approved to serve the adult-use market. This development represents a major shift in New York’s cannabis policy, aiming to establish a regulated market, strengthen local economies, and promote consumer safety
Frequently Asked Questions
Companies such as Cipla (India), MediPharm Labs (Canada), Tilray Brands, Inc. (Canada), Aurora Cannabis Inc. (Canada), Cresco Labs (U.S.), Peace Naturals Project (Canada), and CANOPY GROWTH CORPORATION (Canada) are the major companies in the medical cannabis market.
In July 2023, Carer, an oncology-focused organization in India, announced a partnership with Wholeleaf, a certified medicinal cannabis and cannabidiol producer. In February 2023, Aurora Cannabis Inc., a Canadian global cannabis distributor, partnered with MedReleaf Australia to introduce CraftPlant, a new medical cannabis brand tailored for the Australian market.
The countries covered in the medical cannabis market are U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Switzerland, Austria, Poland, Norway, Ireland, Hungary, Lithuania, rest of Europe, China, Japan, India, South Korea, Australia, Taiwan, Philippines, Thailand, Malaysia, Vietnam, Indonesia, Singapore, rest of Asia-Pacific, Brazil, Argentina, Chili, Colombia, Peru, Venezuela, Ecuador, Uruguay, Paraguay ,Bolivia, Trinidad And Tobago, Curaçao, rest Of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, rest of Middle East and Africa, Guatemala, Costa Rica, Honduras, EL Salvador, Nicaragua, and rest of Central America.
